Related Experiment Videos
Immunologic markers of systemic scleroderma in children
M Błaszczyk1, S Jabłońska, W Szymańska-Jagiełło
1Department of Dermatology, Warsaw School of Medicine, Poland.
Insights
Childhood systemic scleroderma (SSc) subtypes show distinct immunologic markers. Limited SSc in children can present with Scl-70 antibodies, challenging prior assumptions and highlighting the need for careful monitoring.
Area of Science:
- Pediatric Rheumatology
- Immunodermatology
- Autoimmunity
Background:
- Systemic scleroderma (SSc) is a rare autoimmune disease characterized by ত্বক hardening and connective tissue damage.
- Childhood-onset SSc presents unique challenges in diagnosis and management compared to adult-onset SSc.
- Immunologic markers, such as antinuclear antibodies (ANA), play a crucial role in SSc classification and prognosis.
Observation:
- This study analyzed seven children with SSc, categorized into diffuse (n=3) and limited (n=4) types.
- Diffuse SSc cases exhibited high titers of clumpy pattern antinucleolar antibody and severe disease progression, with two fatalities.
- Limited SSc cases showed milder disease, with one patient presenting Scl-70 antibodies, a marker typically associated with diffuse SSc in adults.
Findings:
- A significant finding was the association of Scl-70 antibodies with limited SSc in childhood, even with minimal skin involvement.
- The coexistence of Scl-70 and anticentromere antibodies was observed in one child, contradicting previous beliefs of mutual exclusivity.
- Antinucleolar antibodies were strongly correlated with severe, diffuse SSc in the pediatric cohort.
Implications:
- These findings suggest that limited SSc in children may have different immunologic profiles than in adults.
- Early identification and monitoring of immunologic markers in children with Raynaud's phenomenon or subtle skin changes are crucial for timely SSc diagnosis.
- The study underscores the importance of considering specific immunologic markers for accurate subtyping and predicting disease course in pediatric systemic scleroderma.
Abstract:
This study was performed on seven children with systemic scleroderma, three with the diffuse and four with the limited type. All three patients with diffuse scleroderma had high titers of clumpy pattern antinucleolar antibody on HEp-2 cells. The course of the disease was severe, and two children died. Four children with limited scleroderma had mild disease, and Scl-70 antibody, an immunologic marker that in adults is associated mostly with diffuse scleroderma. In one child Scl-70 antibody and anticentromere antibody coexisted, although previously the two were believed to be mutually exclusive. This study shows that limited scleroderma of childhood with slight cutaneous involvement may be associated with the Scl-70 marker. The findings in 10 adults in whom Raynaud's phenomenon developed in childhood and indurations appeared some years later, point to the significance of careful observation of these children, with repeated testing for immunologic markers of SSc. An important new finding is the association of different types of systemic sclerodermas with specific immunologic markers.